Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | PTIX |
---|---|---|
09:57 ET | 300 | 1.389 |
09:59 ET | 100 | 1.37 |
10:01 ET | 500 | 1.38 |
10:03 ET | 2180 | 1.38 |
10:06 ET | 200 | 1.33 |
12:12 ET | 100 | 1.31 |
01:50 ET | 235 | 1.2499 |
03:38 ET | 112 | 1.31 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Protagenic Therapeutics Inc | 6.1M | -1.1x | --- |
Actavia Life Sciences Inc | 6.0M | -1.0x | --- |
Avenue Therapeutics Inc | 6.0M | -0.1x | --- |
ProtoKinetix Inc | 6.0M | -13.7x | --- |
HST Global Inc | 5.9M | -40.2x | --- |
Kazia Therapeutics Ltd | 9.1M | -0.5x | --- |
Protagenic Therapeutics, Inc. is a biopharmaceutical company specializing in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide (TCAP), an endogenous brain signaling peptide that can dampen overactive stress responses. Its lead compound is a 41-amino-acid synthetic peptide, which focuses on treating various neuro-psychiatric conditions, including depression, anxiety, and post-traumatic stress disorder (PTSD). It operates with a novel mechanism, mirroring the active part of the natural brain hormone TCAP, thereby reducing circulating cortisol levels. In addition, it has a portfolio of earlier stage neuropeptides targeting the TCAP pathway that are in preclinical evaluation. The initial dosage form is intended as a subcutaneous injection but is also amenable to other routes of administration including sublingually or intra-nasally.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $6.1M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 4.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.07 |
EPS | $-1.15 |
Book Value | $0.83 |
P/E Ratio | -1.1x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.